• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Anti-HBs levels in children under the age of two years born to HBV carrier mothers after immunoprophylaxis: a multicenter cross-sectional study.HBV 携带母亲所生 2 岁以下儿童的抗-HBs 水平:一项多中心横断面研究。
BMC Pediatr. 2021 Nov 4;21(1):492. doi: 10.1186/s12887-021-02967-8.
2
Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.乙肝免疫接种对预防乙肝病毒母婴传播及婴儿对乙肝疫苗免疫反应的影响。
Vaccine. 2014 Oct 21;32(46):6091-7. doi: 10.1016/j.vaccine.2014.08.078. Epub 2014 Sep 18.
3
Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure.改进免疫接种对乙型肝炎病毒母婴传播的保护作用及与免疫预防失败相关的危险因素
Medicine (Baltimore). 2016 Aug;95(34):e4390. doi: 10.1097/MD.0000000000004390.
4
Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.中国4个省份乙肝表面抗原阳性母亲所生婴儿的疫苗接种后血清学检测
Vaccine. 2017 Jul 24;35(33):4229-4235. doi: 10.1016/j.vaccine.2017.06.019. Epub 2017 Jun 23.
5
[Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].[贵州省孕期高病毒载量及HBeAg阳性乙型肝炎病毒母婴传播阻断的临床研究]
Zhonghua Gan Zang Bing Za Zhi. 2018 Dec 20;26(12):945-950. doi: 10.3760/cma.j.issn.1007-3418.2018.12.013.
6
Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.高 HIV 流行地区产前乙型肝炎病毒血清流行率、危险因素、妊娠结局和出生后 24 个月内的垂直传播率。
BMC Infect Dis. 2023 Oct 27;23(1):736. doi: 10.1186/s12879-023-08523-2.
7
Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.孕期使用乙型肝炎免疫球蛋白预防乙肝病毒母婴传播。
Cochrane Database Syst Rev. 2017 Feb 11;2(2):CD008545. doi: 10.1002/14651858.CD008545.pub2.
8
Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis.新生儿被动-主动免疫预防后 HBsAg 阳性母亲所生儿童的隐匿性乙型肝炎病毒感染。
Infection. 2015 Jun;43(3):307-14. doi: 10.1007/s15010-015-0733-6. Epub 2015 Feb 10.
9
Outcomes of the national programme on prevention of mother-to-child transmission of hepatitis B virus in China, 2016-2017.中国 2016-2017 年乙型肝炎母婴传播预防国家项目结局。
Infect Dis Poverty. 2019 Aug 5;8(1):65. doi: 10.1186/s40249-019-0576-y.
10
Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.股静脉血或脐带血中乙肝病毒血清学阳性标志物不应作为新生儿宫内感染的证据。
BMC Infect Dis. 2016 Aug 12;16(1):408. doi: 10.1186/s12879-016-1754-1.

引用本文的文献

1
Immune response and associated factors to Hepatitis B vaccination among children under five attending care at mulago hospital.在穆拉戈医院接受护理的五岁以下儿童中,对乙肝疫苗接种的免疫反应及相关因素
BMC Pediatr. 2025 Mar 8;25(1):175. doi: 10.1186/s12887-024-05366-x.
2
Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers.细胞因子 IL-5 和 HGF:联合预测 HBsAg 阳性母亲所生婴儿出生时对乙型肝炎疫苗的无/低免疫应答。
Front Cell Infect Microbiol. 2024 Mar 1;14:1332666. doi: 10.3389/fcimb.2024.1332666. eCollection 2024.
3
The prevalence of hepatitis B in Chinese general population from 2018 to 2022: a systematic review and meta-analysis.2018 年至 2022 年中国一般人群乙型肝炎流行率:系统评价和荟萃分析。
BMC Infect Dis. 2024 Feb 16;24(1):211. doi: 10.1186/s12879-024-09103-8.
4
Seroconversion among children with HBsAg-positive mothers in Indonesia and factors affecting the anti-HBs titers.印度尼西亚乙肝表面抗原阳性母亲所生儿童的血清学转换及影响抗乙肝表面抗体滴度的因素。
Glob Epidemiol. 2024 Jan 5;7:100135. doi: 10.1016/j.gloepi.2024.100135. eCollection 2024 Jun.
5
Vaginal Delivery and Breastfeeding Benefit Infant Immune Response to Hepatitis B Vaccine: A Prospective Cohort Study.阴道分娩和母乳喂养有益于婴儿对乙肝疫苗的免疫反应:一项前瞻性队列研究。
J Clin Transl Hepatol. 2023 Aug 28;11(4):899-907. doi: 10.14218/JCTH.2022.00032S. Epub 2023 Mar 7.

本文引用的文献

1
Eliminating mother-to-child transmission of HBV: progress and challenges in China.消除乙型肝炎病毒母婴传播:中国的进展与挑战。
Front Med. 2020 Feb;14(1):21-29. doi: 10.1007/s11684-020-0744-2. Epub 2020 Jan 22.
2
State of viral hepatitis care in 16 countries of Central and Eastern European Region.中东欧地区16个国家的病毒性肝炎防治状况。
Cent Eur J Public Health. 2019 Sep;27(3):212-216. doi: 10.21101/cejph.a5486.
3
New Markers in Monitoring the Reactivation of Hepatitis B Virus Infection in Immunocompromised Hosts.监测免疫功能低下宿主乙型肝炎病毒再激活的新标志物。
Viruses. 2019 Aug 25;11(9):783. doi: 10.3390/v11090783.
4
Outcomes of the national programme on prevention of mother-to-child transmission of hepatitis B virus in China, 2016-2017.中国 2016-2017 年乙型肝炎母婴传播预防国家项目结局。
Infect Dis Poverty. 2019 Aug 5;8(1):65. doi: 10.1186/s40249-019-0576-y.
5
Immunisation after hepatitis B polyvalent vaccination among children in South Kivu Province, Democratic Republic of the Congo.刚果民主共和国南基伍省儿童乙肝多价疫苗接种后的免疫接种。
S Afr Med J. 2019 Apr 29;109(5):319-322. doi: 10.7196/SAMJ.2019.v109i5.12819.
6
Prevention of perinatal hepatitis B virus transmission.预防围生期乙型肝炎病毒传播。
Arch Gynecol Obstet. 2019 Aug;300(2):251-259. doi: 10.1007/s00404-019-05190-0. Epub 2019 May 16.
7
Countdown to 2030: eliminating hepatitis B disease, China.倒计时 2030:消除乙型肝炎疾病,中国。
Bull World Health Organ. 2019 Mar 1;97(3):230-238. doi: 10.2471/BLT.18.219469. Epub 2019 Jan 28.
8
Hepatitis B virus vaccination and revaccination response in children diagnosed with coeliac disease : a multicentre prospective study.患有乳糜泻儿童的乙肝疫苗接种及再接种反应:一项多中心前瞻性研究
Acta Gastroenterol Belg. 2019 Jan-Mar;82(1):27-30.
9
Hepatitis B virus sero-prevalence amongst pregnant women in the Gambia.冈比亚孕妇乙型肝炎病毒血清流行率。
BMC Infect Dis. 2019 Mar 15;19(1):259. doi: 10.1186/s12879-019-3883-9.
10
Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017.迈向乙型肝炎控制和消除乙型肝炎病毒母婴传播的进展 - 西太平洋区域,2005-2017 年。
MMWR Morb Mortal Wkly Rep. 2019 Mar 1;68(8):195-200. doi: 10.15585/mmwr.mm6808a2.

HBV 携带母亲所生 2 岁以下儿童的抗-HBs 水平:一项多中心横断面研究。

Anti-HBs levels in children under the age of two years born to HBV carrier mothers after immunoprophylaxis: a multicenter cross-sectional study.

机构信息

Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, No. 17 Section 3, Renmin South Road, Chengdu, Sichuan, 610041, People's Republic of China.

Department of Medical Laboratory Science, Women's Hospital, School of Medicine, Zhejiang University, Xueshi Road 1, Hangzhou, Zhejiang, 310006, People's Republic of China.

出版信息

BMC Pediatr. 2021 Nov 4;21(1):492. doi: 10.1186/s12887-021-02967-8.

DOI:10.1186/s12887-021-02967-8
PMID:34736435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8567679/
Abstract

BACKGROUND

Serological testing for the presence of Hepatitis B Virus (HBV) markers and anti-HBs titers in infants born to HBsAg positive women is critically important for estimation in immunisation programme.

METHODS

This was a multi-center and cross-sectional study conducted in Zhejiang province, China. Children aged 7 to 24 months born to HBsAg positive women during December 2018 to February 2019, completed additional HBV serological markers screening. We indicated distribution of HBV serological markers and anti-HBs titers in children. Multiple logistic regression model with adjusted odds ratio and 95% confidence interval (OR and 95% CI) was used to explore the factors associated with inadequate immune response (anti-HBs titers< 100 mIU/ml) among children.

RESULTS

A total of 1849 children were included. Overall 25 children tested HBsAg positive, giving HBsAg positive rate of 1.35%(95%CI: 0.83-1.88%). 92.00% (23/25) HBsAg positive children were delivered by HBeAg positive mothers. The proportion of protective seroconversion (anti-HBs titers≥10mIU/ml) was 99.29% in all children, and 86.48% children were reported with adequate anti-HBs titers (≥100mIU/ml).We found a significant higher proportions of early antenatal health care (< 13 gestational weeks), and term birth in children with adequate response compared with inadequate response (all P < 0.05). Logistic regression showed preterm birth was a negative factor for inadequate anti-HBs titers (OR = 1.868,95%CI 1.132-3.085,P = 0.015).

CONCLUSIONS

Children delivered by HBeAg positive mothers had higher risk of vertical transmission of HBV, despite completion of 3 doses of hepatitis B vaccine and HBIG injection. Inadequate anti-HBs level was significantly associated with preterm birth in HBsAg positive women.

摘要

背景

对乙型肝炎病毒 (HBV) 标志物和抗-HBs 滴度呈阳性的 HBsAg 阳性妇女所生婴儿进行血清学检测,对于评估免疫接种计划至关重要。

方法

这是一项在中国浙江省进行的多中心、横断面研究。2018 年 12 月至 2019 年 2 月期间,HBsAg 阳性妇女所生的 7 至 24 月龄儿童完成了额外的 HBV 血清学标志物筛查。我们说明了儿童中 HBV 血清学标志物和抗-HBs 滴度的分布情况。采用调整后的比值比和 95%置信区间(OR 和 95%CI)的多因素逻辑回归模型,探讨了与儿童中免疫反应不足(抗-HBs 滴度<100 mIU/ml)相关的因素。

结果

共纳入 1849 名儿童。共有 25 名儿童 HBsAg 阳性,HBsAg 阳性率为 1.35%(95%CI:0.83-1.88%)。25 名 HBsAg 阳性儿童中,92.00%(23/25)为 HBeAg 阳性母亲所生。所有儿童的保护性血清转化率(抗-HBs 滴度≥10 mIU/ml)比例为 99.29%,86.48%的儿童报告抗-HBs 滴度充足(≥100 mIU/ml)。我们发现,与免疫反应不足的儿童相比,有足够反应的儿童中,早期产前保健(<13 孕周)和足月产的比例显著较高(均 P<0.05)。Logistic 回归显示,早产是导致抗-HBs 滴度不足的一个负面因素(OR=1.868,95%CI 1.132-3.085,P=0.015)。

结论

尽管完成了 3 剂乙肝疫苗和 HBIG 注射,但 HBeAg 阳性母亲所生的儿童仍有较高的 HBV 垂直传播风险。抗-HBs 水平不足与 HBsAg 阳性妇女的早产显著相关。